Literature DB >> 16918615

An evaluation of dose/unit area and time as key factors influencing the elicitation capacity of methylchloroisothiazolinone/methylisothiazolinone (MCI/MI) in MCI/MI-allergic patients.

Claus Zachariae1, Anne Lerbaek, Pauline M McNamee, John E Gray, Mike Wooder, Torkil Menné.   

Abstract

Methylchloroisothiazolinone and methylisothiazolinone (MCI/MI) contact allergy affects 1-3% of patch-tested patients in European centres. The aim of the present study was to evaluate the importance of the factors--time and concentration (dose/per unit area)--in the elicitation capacity by means of a repeated open application test (ROAT) experimental design. The study was designed as a double-blind, placebo-controlled, dose-response ROAT preceded by a diagnostic patch testing. 25 subjects with confirmed MCI/MI allergy and 10 healthy, non-MCI/MI allergic control subjects were exposed to 0.025 microg/cm2 (2 p.p.m.) of MCI/MI/unit area of the skin for 4 weeks. After a wash-out period of at least 4 weeks, the subjects were exposed to 0.094 microg/cm2 (7.5 p.p.m.) of MCI/MI/unit area of the skin for 4 weeks. The study showed the importance of both time and exposure in the elicitation process. It demonstrated that the elicitation threshold for MCI/MI is expected to be in the proximity of 0.025 microg/cm2 although it was not possible to establish a definitive elicitation threshold for MCI/MI in this study.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16918615     DOI: 10.1111/j.1600-0536.2006.00895.x

Source DB:  PubMed          Journal:  Contact Dermatitis        ISSN: 0105-1873            Impact factor:   6.600


  2 in total

1.  Moisturizer allergy: diagnosis and management.

Authors:  Matthew J Zirwas; Sarah A Stechschulte
Journal:  J Clin Aesthet Dermatol       Date:  2008-11

2.  Isothiazolinone Content of US Consumer Adhesives: Ultrahigh-Performance Liquid Chromatographic Mass Spectrometry Analysis.

Authors:  Molly C Goodier; Lun-Yi Zang; Paul D Siegel; Erin M Warshaw
Journal:  Dermatitis       Date:  2019 Mar/Apr       Impact factor: 4.845

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.